Table 1 Descriptive analysis of study sample (n = 550)
Not recently tested n = 378 (68.7%) | Recently tested n = 172 (31.3%) | p Value | Total n = 550 | |
|---|---|---|---|---|
Questionnaire | 0.005 | |||
Online | 121 (32.0) | 35 (20.3) | 156 (28.4) | |
Face-to-face | 257 (68.0) | 137 (79.7) | 394 (71.6) | |
Age (years) | 0.135 | |||
Median [IQR] | 34 [29–42] | 33 [27–40] | 34 [28–41] | |
Gender | 0.289 | |||
Men | 296 (79.8) | 143 (83.6) | 439 (81.0) | |
Women | 75 (20.2) | 28 (16.4) | 103 (19.0) | |
Employment | 0.002 | |||
Unemployed | 244 (66.8) | 136 (80.0) | 380 (71.0) | |
Employed | 121 (33.2) | 34 (20.0) | 155 (29.0) | |
Unstable housing | 0.026 | |||
No | 299 (79.9) | 122 (71.3) | 421 (77.2) | |
Yes | 75 (20.1) | 49 (28.7) | 124 (22.8) | |
Recent incarceration | 0.018 | |||
No | 327 (89.1) | 138 (81.7) | 465 (86.8) | |
Yes | 40 (10.9) | 31 (18.3) | 71 (13.2) | |
Currently on OAT | 0.845 | |||
No | 109 (28.8) | 51 (29.7) | 160 (29.1) | |
Yes | 269 (71.2) | 121 (70.3) | 390 (70.9) | |
Opioid injected most frequently | 0.372 | |||
Buprenorphine | 173 (45.8) | 81 (47.1) | 254 (46.2) | |
Heroin | 68 (18.0) | 26 (15.1) | 94 (17.1) | |
Morphine | 58 (15.3) | 26 (15.1) | 84 (15.3) | |
Methadone | 16 (4.2) | 14 (8.1) | 30 (5.5) | |
Other a | 63 (16.7) | 25 (14.5) | 88 (16.0) | |
Other non-opioid substances injected | 0.111 | |||
No | 177 (46.8) | 68 (39.5) | 245 (44.5) | |
Yes | 201 (53.2) | 104 (60.5) | 305 (55.5) | |
Time since first opioid injection (years) | 0.1021 | |||
Median [IQR] | 7 [3–12] | 6 [3–10] | 7 [3–11] | |
Drug injection frequency during the previous month (days) | 0.7861 | |||
Median [IQR] | 30 [20–30] | 30 [15–30] | 30 [20–30] | |
Sharing injection equipment | 0.601 | |||
No | 302 (82.3) | 143 (84.1) | 445 (82.9) | |
Yes | 65 (17.7) | 27 (15.9) | 92 (17.1) | |
Disclosure of injection practicesb | 0.001 | |||
Yes | 320 (88.2) | 163 (97.0) | 483 (91.0) | |
No | 43 (11.8) | 5 (3.0) | 48 (9.0) | |